Stroke, IschemicNCT03507517
Quality Control Project of Stroke in Liaoning Province
An observational study of Stroke, Ischemic, run by Hui-Sheng Chen.
Trial summary
To reduce the incidence of stroke and standard the treatment of stroke in Liaoning Province, the present study should be conducted. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Stroke, Ischemic
- How many people
- 10,000 participants
- Where
- No sites listed yet
- Study dates
- 1 Nov 2015to 1 Mar 2018
- How long will I take part?
- 2 Years
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: All patients diagnosed with ischemic stroke
Who may be able to join
- ischemic stroke
Who cannot join
- disagreed patients
About this study
Official title: Quality Control Project of Secondary Prevention and Treatment of Stroke in Liaoning Province
To reduce the incidence of stroke and standard the treatment of stroke in Liaoning Province, the present study should be conducted.
- Conditions
- Stroke, Ischemic
- Keywords
- prevention
- Medical subject headings
- Ischemic Stroke
What is being measured
The primary outcome is the main question the study is designed to answer.
Key Performance Indicator of Secondary Prevention of Stroke in Liaoning Province
The real KPI data such as intravenous thrombolysis number and quality, statin use, anti-platelet drugs, VET prevention, etc
Measured: 2 years
Secondary outcomes (1)
The results of Stroke prevention in Liaoning Province
The real data such as good neurological function outcome, stroke recurrence rate, death rate, etc.
Measured: 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Apr 2018
- Study start1 Nov 2015
- Primary completion1 Dec 2017
- Study completion1 Mar 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stroke, IschemicStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 10,000 participants (estimated)
- Target duration
- 2 Years
Sponsor and investigators
- Lead sponsor
- Hui-Sheng Chen
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Hui-Sheng Chen, General Hospital of Shenyang Military Region
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03507517
- Sponsor's protocol ID
- 2017275212
- Status last verified
- Jul 2018
- First submitted
- 26 Nov 2017
- Last updated
- 13 Jul 2018
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Jul 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Quality Control Project of Secondary Prevention and Treatment of Stroke in Liaoning Province
- ClinicalTrials.gov ID
- NCT03507517
- Acronym / sponsor ID
- 2017275212
- Conditions
- Stroke, Ischemic
- Keywords
- prevention
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 10,000 participants (estimated)
- Lead sponsor
- Hui-Sheng ChenUniversity, hospital or other
- Study start
- 1 Nov 2015 (actual)
- Primary completion
- 1 Dec 2017 (actual)
- Study completion
- 1 Mar 2018 (actual)
- First posted
- 25 Apr 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To reduce the incidence of stroke and standard the treatment of stroke in Liaoning Province, the present study should be conducted.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 2 Years
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All patients diagnosed with ischemic stroke
Key inclusion criteria (1 listed)
- ischemic stroke
Key exclusion criteria (1 listed)
- disagreed patients
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Key Performance Indicator of Secondary Prevention of Stroke in Liaoning Province
Time frame: 2 years
The real KPI data such as intravenous thrombolysis number and quality, statin use, anti-platelet drugs, VET prevention, etc
1 secondary outcome
The results of Stroke prevention in Liaoning Province
Time frame: 2 years
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jul 2018.
- Individual participant dataSharing planned: No
Related trials for Stroke, Ischemic
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
RecruitingObservational study
ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window
Acute Ichemic Stroke
Not yet recruiting
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Acute Ischemic Stroke, Basilar Artery Occlusion
Active, not recruiting
Improving Visual Field Deficits With Noninvasive Brain Stimulation
Visual Field Defect, Peripheral, Stroke
Recruiting
Biomarkers of Paired VNS
Stroke, Ischemic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Stroke, Ischemic, run by Hui-Sheng Chen.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Key Performance Indicator of Secondary Prevention of Stroke in Liaoning Province (time frame: 2 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2018.